Options for correcting nephrogenic anemia in a patient with HIV and chronic kidney disease. Case report

Options for correcting nephrogenic anemia in a patient with HIV and chronic kidney disease. Case report

Anemia is a distinctive manifestation of chronic kidney disease (CKD); it occurs already from stage III CKD and is observed in the vast majority of patients with end-stage renal disease. The primary mechanism of renal anemia is a decrease in the production of endogenous erythropoietin; deficiency co...

Full description

Saved in:

Bibliographic Details
Main Author:	Victor V. Fomin
Format:	Article
Language:	Russian
Published:	ZAO "Consilium Medicum" 2024-11-01
Series:	Consilium Medicum
Subjects:	anemia chronic kidney disease human immunodeficiency virus erythropoietin alpha erythropoietin beta
Online Access:	https://consilium.orscience.ru/2075-1753/article/viewFile/642176/157960
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk Factors Associated with Hyporesponsiveness to Erythropoietin in Chronic Kidney Disease Patients on Hemodialysis Who Present Anemia: A Multicenter Case-Control Study
by: Carlos Perez Tulcanaza, et al.
Published: (2025-06-01)

Anemia Management Strategies in Diabetic Kidney Disease: A Comprehensive Review
by: Krishna S. Upadhye, et al.
Published: (2025-04-01)

Treatment of anemia of chronic kidney disease caused by ANCA associated vasculitis with roxadustat:one case report with a literature review
by: Xiao Xiang, et al.
Published: (2021-01-01)

Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study
by: Ni Made Hustrini, et al.
Published: (2019-11-01)

Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study
by: Ni Made Hustrini, et al.
Published: (2019-11-01)

Study the levels of Erythropoietin, Glutathione and Malondialdehyde in women with gestational anemia
by: Aaraf Sabah Abdulwaheed, et al.
Published: (2023-02-01)

CLINICOPATHOLOGICAL CORRELATION OF ANEMIA IN CHRONIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY IN A TERTIARY CARE HOSPITAL.
by: Dr. S Sivajyothsna, et al.
Published: (2025-03-01)

Influence of TNF-alpha on the efficacy of anemia correction in patients with lymphoproliferative disorders
by: N. A. Romanenko, et al.
Published: (2022-11-01)

FEATURES OF REGULATION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5D
by: E. S. Lapina, et al.
Published: (2016-03-01)

Cohort Prospective Study to Evaluate Immunogenicity of Epodion® (Biosimilar Epoetin-α) in Anemia Associated with Chronic Kidney Disease (CKD) Patients
by: Nova Angginy, et al.
Published: (2022-09-01)

The Potential Benefits of Pegylated Erythropoietin in Lowering Anemia in Individuals with Chronic Kidney Disease
by: Suresh Kumar RATHI
Published: (2024-08-01)

Anemia in cancer patients: current treatment options (review)
by: V. M. Chernov, et al.
Published: (2014-07-01)

EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY
by: V. M. Provotorov, et al.
Published: (2016-01-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Sofia Omari, et al.
Published: (2011-05-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Alhossain A. Khalafallah, et al.
Published: (2011-01-01)

Efficacy of L-carnitine combined with erythropoietin in the treatment of hemodialysis-induced renal anemia
by: ZHANG Yong, et al.
Published: (2018-01-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01)

The problem of anemia treatment in patients with chronic heart failure.
by: V. P. Ivanov, et al.
Published: (2018-05-01)

Anemia in renal allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
by: Xiaomeng Zheng, et al.
Published: (2023-12-01)

CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS
by: V. D. Nazarov, et al.
Published: (2018-01-01)

Causes of anemia in patients with gastric cancer during the perioperative period
by: M. A. Giparovich, et al.
Published: (2022-05-01)

Anemia – an independent risk factor of adverse cardiovascular outcomes in women
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Comparative efficacy Shengxuening and polysaccharide iron complex treatment of anemia in patients with peritoneal dialysis
by: SHI Shao-hua, et al.
Published: (2015-01-01)

The difference of efficacy between Shengxuening and Polysaccharide iron complex capsule in treating renal anemia in patients with hemodialysis
by: SU Chao, et al.
Published: (2020-01-01)

THE STUDY OF RENOPROTECTIVE PROPERTIES OF ERYTROPOETIN DERIVATIVES ON THE KIDNEY ISCHEMIA-REPERFUSION MODEL
by: V. V. Elagin, et al.
Published: (2018-12-01)

Recombinant erythropoietin in the treatment of anemia in cancer patients
by: S. V. Vorobiova, et al.
Published: (2022-11-01)

Preoperative Preparation of Patients with Anemia before Shoulder Replacement
by: S. V. Sokolov, et al.
Published: (2021-07-01)

Influence of secondary hyperparathyroidism in management anemia in patients on regular hemodialysis
by: Hamzagić Nedim, et al.
Published: (2020-01-01)

Eprex in the management of anemia related to lymphoproliferative disorders
by: P. N. Barlamov, et al.
Published: (2022-11-01)

The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review
by: Yousuf Abdulkarim Waheed, et al.
Published: (2024-12-01)

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
by: Katarzyna Muras-Szwedziak, et al.
Published: (2023-12-01)

Association of gene polymorphism in ERG rs2836411 with anemia and susceptibility to aortic dissection
by: Ying Wang, et al.
Published: (2024-11-01)

Study on the mechanism of action of NGAL in renal anemia on iron metabolism and erythrocyte maturation
by: WU Xin-hong, et al.
Published: (2019-01-01)

Efficacy of Shengxuening tablets combined with erythropoietin in treatment of renal anemia of diabetic kidney disease stage V patients
by: ZHANG Jian-wei, et al.
Published: (2015-01-01)

A comparison of Erythropoietin hormone level at male diabetic patients with and without nephropathy
by: Esraa Mahdi Zahid, et al.
Published: (2013-12-01)

Anemias in Oncology: Potential of Maintenance Therapy
by: AV Snegovoi, et al.
Published: (2016-07-01)

Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy
by: Christina Antoniadou, et al.
Published: (2025-03-01)

The anemia correction in chronic diseases in perioperative period while performing prosthesis of aortal valve
by: B. M. Gumenyuk
Published: (2020-07-01)